These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1855 related articles for article (PubMed ID: 22101365)

  • 21. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.
    Uemura MT; Robinson JL; Cousins KAQ; Tropea TF; Kargilis DC; McBride JD; Suh E; Xie SX; Xu Y; Porta S; Uemura N; Van Deerlin VM; Wolk DA; Irwin DJ; Brunden KR; Lee VM; Lee EB; Trojanowski JQ
    Acta Neuropathol; 2022 Jan; 143(1):15-31. PubMed ID: 34854996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer's disease: A case report spanning 16 years of memory loss.
    Carlos AF; Koga S; Graff-Radford NR; Baker MC; Rademakers R; Ross OA; Dickson DW; Josephs KA
    Neuropathology; 2024 Apr; 44(2):115-125. PubMed ID: 37525358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
    Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
    Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.
    White LR; Corrada MM; Kawas CH; Cholerton BA; Edland SE; Flanagan ME; Montine TJ
    J Alzheimers Dis; 2023; 95(1):307-316. PubMed ID: 37522210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes.
    Brenowitz WD; Nelson PT; Besser LM; Heller KB; Kukull WA
    Neurobiol Aging; 2015 Oct; 36(10):2702-8. PubMed ID: 26239176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is 'Alzheimer's disease'? The neuropathological heterogeneity of clinically defined Alzheimer's dementia.
    Mehta RI; Schneider JA
    Curr Opin Neurol; 2021 Apr; 34(2):237-245. PubMed ID: 33591030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropathologic differences by race from the National Alzheimer's Coordinating Center.
    Graff-Radford NR; Besser LM; Crook JE; Kukull WA; Dickson DW
    Alzheimers Dement; 2016 Jun; 12(6):669-77. PubMed ID: 27094726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo cortical diffusion imaging relates to Alzheimer's disease neuropathology.
    Torso M; Ridgway GR; Valotti M; Hardingham I; Chance SA; ;
    Alzheimers Res Ther; 2023 Oct; 15(1):165. PubMed ID: 37794477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
    Mohanty R; Ferreira D; Frerich S; Muehlboeck JS; Grothe MJ; Westman E;
    Neurology; 2022 Jul; 99(4):e323-e333. PubMed ID: 35609990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of a Condensed Protocol That Reduces Effort and Cost of NIA-AA Guidelines for Neuropathologic Assessment of Alzheimer Disease.
    Flanagan ME; Marshall DA; Shofer JB; Montine KS; Nelson PT; Montine TJ; Keene CD
    J Neuropathol Exp Neurol; 2017 Jan; 76(1):39-43. PubMed ID: 28062571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.
    Rohn TT
    Brain Res; 2008 Sep; 1228():189-98. PubMed ID: 18634762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.
    Davidson YS; Raby S; Foulds PG; Robinson A; Thompson JC; Sikkink S; Yusuf I; Amin H; DuPlessis D; Troakes C; Al-Sarraj S; Sloan C; Esiri MM; Prasher VP; Allsop D; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
    Acta Neuropathol; 2011 Dec; 122(6):703-13. PubMed ID: 21968532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease-related plaques in nondemented subjects.
    Elobeid A; Rantakömi S; Soininen H; Alafuzoff I
    Alzheimers Dement; 2014 Sep; 10(5):522-9. PubMed ID: 24742915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease.
    Braak H; Braak E
    Neurobiol Aging; 1997; 18(4 Suppl):S85-8. PubMed ID: 9330992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
    Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
    Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing.
    Neltner JH; Abner EL; Baker S; Schmitt FA; Kryscio RJ; Jicha GA; Smith CD; Hammack E; Kukull WA; Brenowitz WD; Van Eldik LJ; Nelson PT
    Brain; 2014 Jan; 137(Pt 1):255-67. PubMed ID: 24271328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 93.